BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26873445)

  • 1. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis.
    Garsen M; Benner M; Dijkman HB; van Kuppevelt TH; Li JP; Rabelink TJ; Vlodavsky I; Berden JH; Rops AL; Elkin M; van der Vlag J
    Am J Pathol; 2016 Apr; 186(4):805-15. PubMed ID: 26873445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
    van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
    Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.
    An X; Zhang L; Yuan Y; Wang B; Yao Q; Li L; Zhang J; He M; Zhang J
    Sci Rep; 2017 Jul; 7(1):6413. PubMed ID: 28743882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of heparanase and the endothelial glycocalyx in the development of proteinuria.
    Garsen M; Rops AL; Rabelink TJ; Berden JH; van der Vlag J
    Nephrol Dial Transplant; 2014 Jan; 29(1):49-55. PubMed ID: 24166469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.
    Garsen M; Sonneveld R; Rops AL; Huntink S; van Kuppevelt TH; Rabelink TJ; Hoenderop JG; Berden JH; Nijenhuis T; van der Vlag J
    J Pathol; 2015 Dec; 237(4):472-81. PubMed ID: 26202309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.
    Kramer A; van den Hoven M; Rops A; Wijnhoven T; van den Heuvel L; Lensen J; van Kuppevelt T; van Goor H; van der Vlag J; Navis G; Berden JH
    J Am Soc Nephrol; 2006 Sep; 17(9):2513-20. PubMed ID: 16899518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase in glomerular diseases.
    van den Hoven MJ; Rops AL; Vlodavsky I; Levidiotis V; Berden JH; van der Vlag J
    Kidney Int; 2007 Sep; 72(5):543-8. PubMed ID: 17519955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase in Kidney Disease.
    van der Vlag J; Buijsers B
    Adv Exp Med Biol; 2020; 1221():647-667. PubMed ID: 32274730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.
    Wijnhoven TJ; van den Hoven MJ; Ding H; van Kuppevelt TH; van der Vlag J; Berden JH; Prinz RA; Lewis EJ; Schwartz M; Xu X
    Diabetologia; 2008 Feb; 51(2):372-82. PubMed ID: 18058084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of heparanase in diseases of the glomeruli.
    Szymczak M; Kuźniar J; Klinger M
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):45-56. PubMed ID: 20049646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of heparanase in overt diabetic nephropathy.
    van den Hoven MJ; Rops AL; Bakker MA; Aten J; Rutjes N; Roestenberg P; Goldschmeding R; Zcharia E; Vlodavsky I; van der Vlag J; Berden JH
    Kidney Int; 2006 Dec; 70(12):2100-8. PubMed ID: 17051139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary heparanase activity in patients with Type 1 and Type 2 diabetes.
    Rops AL; van den Hoven MJ; Veldman BA; Salemink S; Vervoort G; Elving LD; Aten J; Wetzels JF; van der Vlag J; Berden JH
    Nephrol Dial Transplant; 2012 Jul; 27(7):2853-61. PubMed ID: 22187315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria.
    Garsen M; Rops AL; Li J; van Beneden K; van den Branden C; Berden JH; Rabelink TJ; van der Vlag J
    PLoS One; 2016; 11(8):e0160894. PubMed ID: 27505185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis.
    van Gemst JJ; Passmann NJHG; Rops ALWMM; van Kuppevelt TH; Berden JH; Loeven MA; Rabelink TJ; Smeets B; van der Vlag J
    PLoS One; 2021; 16(12):e0261722. PubMed ID: 34941931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis.
    Levidiotis V; Freeman C; Tikellis C; Cooper ME; Power DA
    J Am Soc Nephrol; 2004 Jan; 15(1):68-78. PubMed ID: 14694159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx.
    Garsen M; Lenoir O; Rops AL; Dijkman HB; Willemsen B; van Kuppevelt TH; Rabelink TJ; Berden JH; Tharaux PL; van der Vlag J
    J Am Soc Nephrol; 2016 Dec; 27(12):3545-3551. PubMed ID: 27026367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis.
    Timoshanko JR; Kitching AR; Semple TJ; Holdsworth SR; Tipping PG
    J Am Soc Nephrol; 2005 Sep; 16(9):2646-56. PubMed ID: 16033860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria.
    Raats CJ; Van Den Born J; Berden JH
    Kidney Int; 2000 Feb; 57(2):385-400. PubMed ID: 10652015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase Mediates Intestinal Inflammation and Injury in a Mouse Model of Sepsis.
    Chen S; He Y; Hu Z; Lu S; Yin X; Ma X; Lv C; Jin G
    J Histochem Cytochem; 2017 Apr; 65(4):241-249. PubMed ID: 28170292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo degradation of heparan sulfates in the glomerular basement membrane does not result in proteinuria.
    Wijnhoven TJ; Lensen JF; Wismans RG; Lamrani M; Monnens LA; Wevers RA; Rops AL; van der Vlag J; Berden JH; van den Heuvel LP; van Kuppevelt TH
    J Am Soc Nephrol; 2007 Mar; 18(3):823-32. PubMed ID: 17251387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.